Precision Radiopharmaceuticals: What’s Next?

Panelists: Dr. Jonathan Irish (Session Chair), Dr. Johannes Czernin, Dr. Mark Harfensteller, Dr. Ting-Yim Lee, Dr. Kate Vallis Precision radiopharmaceuticals are making cancer treatments more accurate and effective, yielding promising outcomes for patients. During this session, a panel of industry experts will share insights from the field and offer perspectives on what the future holds for innovation in precision radiopharmaceuticals. Panelists will discuss important topics like discipline integration in the nuclear medicine field, personalized dosing on a large scale, supply chain opportunities, and more.